Per Wester
BioStock Studio: DanCann Pharma on the new agreement
Recently, biotech company DanCann Pharma was able to sign a letter of intent with Canadian Tetra Bio-Pharma for the exclusive distribution rights for cannabinoid-based medicines...
DanCann signs distribution agreement with Tetra Bio-Pharma
Last week, DanCann Pharma signed a letter of intent with...
Panel: Swedish Alzheimer's Society sees the light despite many setbacks
During last week's BioStock Live in Stockholm,...
Article series on Alzheimer's disease, part III: Drug development in Sweden
As more and more people are diagnosed with...
Alzinova's Alzheimer's vaccine ready for clinical trials in 2019
Alzinova takes immunotherapy to the frontline in the fight against...
Notes
Hansa Biopharma appoints new CMO
Perpetua Medical sells assets for SEK 10 million
Lipum reaches 89 percent subscription of warrants
EQL Pharma expands to Germany and the Netherlands
Oncopeptides Pepaxti included in European treatment guidelines
NEWSLETTER
NEWS
In the shadow of the GLP-1 hype: new report criticizes pharmaceutical companies' patent strategies
Five Nordic biotech stock market winners in H1 2025
Chugai and Gero in billion-dollar deal within AI
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The EU's new life science strategy – a step in the right direction or just fluff?
Early signs of spring in an otherwise frosty biotech landscape
